Beating Organs-on-chip dissect human tissues motion states to unlock a new generation of dynamic preclinical models with unprecedented clinical relevance

We operate in different areas



BiomimX® provides advanced human in vitro models to detect drug efficacy and adverse effects, representing a more clinically relevant alternative to existing models.



In line with the new EU Medical Device Regulation (MDR EU 2017/745), BiomimX® offers advanced preclinical models to test medical device efficacy before undergoing clinical trials.



Future developments include envisioned precision medicine approaches, where candidate compounds and therapies are screened on disease- and, ultimately, patient-specific models.

Every tissue in the body is subjected to motion

Check out our pipeline to discover how BiomimX® is exploiting motion to develop relevant preclinical models of human organs and diseases

Our Technology

uBeat® innovative technology brings into microscaled setups a unique combination of mechanical stimulation and 3D architecture

Our Products

uBeat® innovative cell culture setups unlock the possibility to create your own 3D dynamic model

Our Services

Get relevant data form our qualified uBeat® models through our screening services. BiomimX can be your partner in drug development and personalized medicine applications

Meet us

Grenoble, July 4-5, 2022

BiomimX is silver sponsor at #EUROoCS Annual meeting. We believe that Organs on Chip will change the future and for this reason we are happy to support our European Organs on Chip Society. Meet us in Grenoble to learn more about our Beating Organs on Chip solutions.